−£236k
vs Sept 2024Active03809718Private limited companyNew Eltham
AMBE LIMITED
Significant control: Sandeep Askok Patel (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Ambe Limited sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
AMBE LIMITED is an active private limited company (company number 03809718) incorporated on 19 July 1999, registered in New Eltham. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 30 September 2025, showing net assets of −£236k and cash of £11k, with 2 employees on average. Net assets fell 20% on the prior period (−£197k).
Peer position · net assets
By net assets it sits in the bottom quarter of 76 comparable companies in London (median £100, upper quartile £88k).
02
Ownership and control
- Mr Sandeep Askok Patel
- owns 75–100% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 19 July 199927 yrs ago
- Next accounts due
- 30 June 2027in 250 days
- Confirmation statement due
- 2 August 2027in 283 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 46900
- Non-specialised wholesale trade
- SIC 58190
- Other publishing activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£11k
+194%vs Sept 2024Not reported
2
−60%vs Sept 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 September 2025 | −£236k | £11k | £53k | — | — | — | 2 |
| 30 September 2024 | −£197k | £3,780 | £85k | — | — | — | 5 |
Cash per employee£5,558Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-236,465 at 30 September 2025
- Incorporated five or more years agoIncorporated 19 July 1999
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 283 days
- Next accounts duein 250 days
- Accounts period endNet liabilities £236k · small accounts
- Accounts period endNet liabilities £197k · small accounts
- Incorporated
08
Similar companies in London
- Y4U LIMITEDinc. Oct 1999
- IMMUNOCLIN LIMITEDLondon · inc. Jan 2000
- THE ORGANIC PHARMACY LIMITEDLondon · inc. Jun 2000
- NEW FUTURE NOW LIMITEDLondon · inc. Dec 2001
- SALCURA LIMITEDLondon · inc. Apr 2002
- FOCUS PHARMACEUTICALS LIMITEDLondon · inc. Aug 2002
All companies incorporated on 19 July 1999 · in Jul 1999.
09
Reminders for AMBE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.